Total Payments
$6,413
2024 Payments
$777.00
Companies
7
Transactions
14
Medicare Patients
3,342
Medicare Billing
$512,843
Payment Breakdown by Category
Other$4,005 (62.4%)
Consulting$1,277 (19.9%)
Travel$718.21 (11.2%)
Food & Beverage$413.20 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $3,500 | 1 | 54.6% |
| Consulting Fee | $1,277 | 2 | 19.9% |
| Travel and Lodging | $718.21 | 3 | 11.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $505.00 | 2 | 7.9% |
| Food and Beverage | $413.20 | 6 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $4,401 | 8 | $0 (2019) |
| ROCHE DIABETES CARE, INC. | $777.00 | 1 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $500.00 | 1 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $400.00 | 1 | $0 (2017) |
| BETA BIONICS, INC. | $210.59 | 1 | $0 (2023) |
| GENZYME CORPORATION | $105.00 | 1 | $0 (2019) |
| Abbott Laboratories | $19.49 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.00 | 1 | ROCHE DIABETES CARE, INC. ($777.00) |
| 2023 | $210.59 | 1 | BETA BIONICS, INC. ($210.59) |
| 2021 | $519.49 | 2 | Vertex Pharmaceuticals Incorporated ($500.00) |
| 2019 | $4,506 | 9 | Horizon Therapeutics plc ($4,401) |
| 2017 | $400.00 | 1 | SANOFI-AVENTIS U.S. LLC ($400.00) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/01/2024 | ROCHE DIABETES CARE, INC. | Accu-Chek Guide (Device) | Consulting Fee | Cash or cash equivalent | $777.00 | General |
| Category: Diabetes Care | ||||||
| 12/01/2023 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $210.59 | General |
| Category: Automated insulin delivery system | ||||||
| 05/25/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Diabetes Care | ||||||
| 05/24/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 11/16/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $66.35 | General |
| 11/16/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $47.77 | General |
| 11/16/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $34.50 | General |
| 11/16/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $34.50 | General |
| 11/15/2019 | Horizon Therapeutics plc | — | Travel and Lodging | Cash or cash equivalent | $444.60 | General |
| 11/15/2019 | Horizon Therapeutics plc | — | Travel and Lodging | Cash or cash equivalent | $182.77 | General |
| 11/01/2019 | Horizon Therapeutics plc | — | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| 11/01/2019 | Horizon Therapeutics plc | — | Travel and Lodging | Cash or cash equivalent | $90.84 | General |
| 04/24/2019 | GENZYME CORPORATION | SOLIQUA 100/33 (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $105.00 | General |
| Category: DIABETES | ||||||
| 06/15/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 902 | 1,293 | $471,345 | $118,143 |
| 2022 | 6 | 866 | 1,207 | $471,085 | $126,161 |
| 2021 | 9 | 942 | 3,832 | $600,045 | $187,851 |
| 2020 | 8 | 632 | 921 | $311,465 | $80,688 |
Total Patients
3,342
Total Services
7,253
Medicare Billing
$512,843
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 336 | 504 | $214,300 | $52,413 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 195 | 296 | $162,800 | $43,822 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $39,375 | $10,450 | 26.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $20,300 | $5,546 | 27.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 63 | 127 | $25,400 | $3,712 | 14.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 204 | 262 | $9,170 | $2,201 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 337 | 517 | $199,410 | $53,673 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 189 | 267 | $135,450 | $39,875 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 109 | 109 | $57,225 | $15,033 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 62 | 62 | $41,800 | $12,198 | 29.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 91 | 172 | $34,400 | $5,146 | 15.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 78 | 80 | $2,800 | $236.62 | 8.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 330 | 574 | $195,160 | $61,967 | 31.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 165 | 257 | $116,935 | $40,910 | 35.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 35 | 2,460 | $113,160 | $40,332 | 35.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 145 | 145 | $76,125 | $20,987 | 27.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 74 | 74 | $48,100 | $15,311 | 31.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 80 | 196 | $39,200 | $6,133 | 15.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 22 | $5,060 | $1,470 | 29.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 35 | 41 | $4,100 | $553.91 | 13.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 63 | 63 | $2,205 | $186.00 | 8.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 142 | 244 | $111,020 | $29,658 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 175 | 279 | $94,860 | $25,300 | 26.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 52 | 52 | $33,800 | $9,817 | 29.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 48 | 48 | $25,200 | $6,254 | 24.8% |
About Dr. Melissa Katz, MD
Dr. Melissa Katz, MD is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669569745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Katz, MD has received a total of $6,413 in payments from pharmaceutical and medical device companies, with $777.00 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Honoraria" ($3,500).
As a Medicare-enrolled provider, Katz has provided services to 3,342 Medicare beneficiaries, totaling 7,253 services with total Medicare billing of $512,843. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location New York, NY
- Active Since 10/09/2006
- Last Updated 09/19/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669569745
Products in Payments
- Accu-Chek Guide (Device) $777.00
- SOLIQUA (Drug) $400.00
- iLet Bionic Pancreas (Device) $210.59
- SOLIQUA 100/33 (Drug) $105.00
- FreeStyle Libre 2 (Device) $19.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Internal Medicine $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Internal Medicine $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M